Identification of an Apolipoprotein A-I Structural Element That Mediates Cellular Cholesterol Efflux and Stabilizes ATP Binding Cassette Transporter A1*

Synthetic peptides were used in this study to identify a structural element of apolipoprotein (apo) A-I that stimulates cellular cholesterol efflux and stabilizes the ATP binding cassette transporter A1 (ABCA1). Peptides (22-mers) based on helices 1 (amino acids 44–65) and 10 (amino acids 220–241) of apoA-I had high lipid binding affinity but failed to mediate ABCA1-dependent cholesterol efflux, and they lacked the ability to stabilize ABCA1. The addition of helix 9 (amino acids 209–219) to either helix 1 (creates a 1/9 chimera) or 10 (9/10 peptide) endowed cholesterol efflux capability and ABCA1 stabilization activity similar to full-length apoA-I. Adding helix 9 to helix 1 or 10 had only a small effect on lipid binding affinity compared with the 22-mer peptides, indicating that helix length and/or determinants on the polar surface of the amphipathic α-helices is important for cholesterol efflux. Cholesterol efflux was specific for the structure created by the 1/9 and 9/10 helical combinations, as 33-mers composed of helices 1 and 3 (1/3), 2/9, and 4/9 failed to mediate cholesterol efflux in an ABCA1-dependent manner. Transposing helices 9 and 10 (10/9 peptide) did not change the class Y structure, hydrophobicity, or amphiphilicity of the helical combination, but the topography of negatively charged amino acids on the polar surface was altered, and the 10/9 peptide neither mediated ABCA1-dependent cholesterol efflux nor stabilized ABCA1 protein. These results suggest that a specific structural element possessing a linear array of acidic residues spanning two apoA-I amphipathic α-helices is required to mediate cholesterol efflux and stabilize ABCA1.

[1]  B. Brewer,et al.  Phosphorylation and Stabilization of ATP Binding Cassette Transporter A1 by Synthetic Amphiphilic Helical Peptides* , 2004, Journal of Biological Chemistry.

[2]  M. Freeman,et al.  ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux Published, JLR Papers in Press, November 16, 2003. DOI 10.1194/jlr.M300355-JLR200 , 2004, Journal of Lipid Research.

[3]  M. Freeman,et al.  Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. , 2004, Biochemistry.

[4]  A. Vaughan,et al.  Phospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells* , 2003, Journal of Biological Chemistry.

[5]  A. Tall,et al.  Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I* , 2003, Journal of Biological Chemistry.

[6]  A. Tall,et al.  Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Holvoet,et al.  Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model* , 2003, Journal of Biological Chemistry.

[8]  O. Francone,et al.  ATVB In Focus Role of ABCA1 in Cellular Cholesterol Efflux and Reverse Cholesterol Transport , 2003 .

[9]  H. Brewer,et al.  Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200475-JLR200 , 2003, Journal of Lipid Research.

[10]  A. von Eckardstein,et al.  The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux , 2003, The Journal of Biological Chemistry.

[11]  P. Linsel-Nitschke,et al.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. , 2003, The Journal of clinical investigation.

[12]  S. Witting,et al.  The Role of Apolipoprotein A-I Helix 10 in Apolipoprotein-mediated Cholesterol Efflux via the ATP-binding Cassette Transporter ABCA1* , 2002, The Journal of Biological Chemistry.

[13]  P. Natarajan,et al.  Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-I(Milano). , 2002, Biochemical and biophysical research communications.

[14]  B. McManus,et al.  Increased ABCA1 activity protects against atherosclerosis. , 2002, The Journal of clinical investigation.

[15]  S. Yokoyama,et al.  Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation* , 2002, The Journal of Biological Chemistry.

[16]  M. Oda,et al.  Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. , 2002, Biochemistry.

[17]  R. F. Hoyt,et al.  The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Rigneault,et al.  Specific Docking of Apolipoprotein A-I at the Cell Surface Requires a Functional ABCA1 Transporter* , 2001, The Journal of Biological Chemistry.

[19]  H. Brewer,et al.  Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. , 2001, Biochemical and biophysical research communications.

[20]  T. Forte,et al.  Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. , 2001, Biochemistry.

[21]  A. Tall,et al.  Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.

[22]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Langmann,et al.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.

[24]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[25]  K. Weisgraber,et al.  Apolipoprotein-mediated Plasma Membrane Microsolubilization , 1999, The Journal of Biological Chemistry.

[26]  T. Forte,et al.  Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. , 1999, Journal of lipid research.

[27]  G. Anantharamaiah,et al.  Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes. , 1998, Biochemistry.

[28]  H. Brewer,et al.  Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[29]  D. Sviridov,et al.  Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants* , 1996, The Journal of Biological Chemistry.

[30]  G. Anantharamaiah,et al.  Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[31]  G. Francis,et al.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.

[32]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[33]  R. Lees,et al.  Homozygous Tangier disease and cardiovascular disease. , 1994, Atherosclerosis.

[34]  L. McLean,et al.  Kinetics of the interaction of amphipathic α-helical peptides with phosphatidylcholines , 1993 .

[35]  R. Epand,et al.  Effect of end group blockage on the properties of a class A amphipathic helical peptide , 1993, Proteins.

[36]  T. Forte,et al.  Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. , 1993, Journal of lipid research.

[37]  W. J. Johnson,et al.  Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. , 1992, Journal of lipid research.

[38]  G. Anantharamaiah,et al.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.

[39]  M. Phillips,et al.  Cholesterol efflux from arterial wall cells , 1991 .

[40]  S. Yokoyama,et al.  Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.

[41]  P. D. Henry Atherogenesis, calcium and calcium antagonists. , 1990, The American journal of cardiology.

[42]  B. Rifkind High-density lipoprotein cholesterol and coronary artery disease: survey of the evidence. , 1990, The American journal of cardiology.

[43]  D. Eisenberg Three-dimensional structure of membrane and surface proteins. , 1984, Annual review of biochemistry.

[44]  David Eisenberg,et al.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.

[45]  H. Brewer,et al.  Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). , 1980, Annals of internal medicine.

[46]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[47]  O. Stein,et al.  The removal of cholesterol from Landschütz ascites cells by high-density apolipoprotein. , 1973, Biochimica et biophysica acta.